Latest Payments News

PointsBet Holdings Limited has issued a supplementary statement urging shareholders to reject betr Entertainment’s increased scrip offer, reaffirming support for MIXI Australia’s competing cash bid. The board highlights risks tied to betr’s offer and underscores the superior value of the MIXI proposal.

Cosmos Exploration’s optioned entity, EAU Lithium, has agreed to acquire a fully constructed pilot plant from Vulcan Energy Resources to advance lithium extraction testing in Bolivia. This move strengthens Cosmos’ strategic foothold in one of the world’s most promising lithium regions.

Ramsay Health Care has confirmed the payment of a fully franked ordinary dividend on its perpetual preference securities, clearing prior approval conditions and setting a payment date for October 2025.

Shine Justice Ltd reported a 4.4% rise in FY25 revenue to $204.4 million, alongside major legal settlements and leadership changes, signaling renewed growth momentum.

Ramsay Health Care has announced a fully franked ordinary dividend of AUD 0.40 per share for the six months ending June 2025, signaling steady returns for shareholders.

Greatland Resources Limited has reported a robust unaudited FY2025 result, generating $337.3 million net profit after tax from seven months of Telfer gold-copper mine operations, alongside a successful ASX listing and strong cash flow.

Westgold Resources Limited has announced a 3 cent per share final dividend for the financial year ending June 2025, payable in October. The dividend is unfranked, reflecting the company’s current tax position.

Pengana Capital Group reported a strong turnaround in FY 2025 profitability, driven by a surge in private credit funds under management and successful new product launches. The firm’s strategic shift towards private markets is reshaping its revenue profile and balance sheet strength.

Lifestyle Communities reported a challenging FY25 with a significant statutory loss driven by a VCAT ruling, yet signs of sales recovery and a refreshed strategy offer a path forward.

Dimerix Limited reported a 22% reduction in its FY2025 loss to $13.25 million, driven by strong licensing revenues and advancing its pivotal Phase 3 clinical trial for DMX-200. The company secured new global partnerships valued at up to AU$1.4 billion, bolstering its cash reserves and commercial prospects.

Perpetual Limited has announced an ordinary unfranked dividend of AUD 0.54 per share for the half-year ending June 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a choice to reinvest without discount.

Perpetual Limited reported a modest 2% revenue increase for FY25, yet its net profit after tax plunged by 88%, prompting a cautious outlook despite a declared final dividend.